AKEBIA THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
AKEBIA THERAPEUTICS, INC. (AKBA) reported Diluted Shares Outstanding (Weighted Average) of 269.60 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 269.60M shares, a 0.55% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 267.05M shares, a 10.53% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 240.59M shares, a 9.98% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 274.37M shares, a 30.44% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 257.16M shares, a 21.91% increase from fiscal 2024.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 210.95M shares, a 12.53% increase from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 187.47M shares, a 2.56% increase from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 182.78M shares, a 10.14% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 269.60M shares 10-Q · filed 2026-08-05 | 268.33M shares 10-Q · filed 2026-08-05 | 259.08M shares derived: average of 3 quarters · filed 2026-08-05 | 262.90M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 267.05M shares 10-Q · filed 2026-05-07 | 253.82M shares derived: average of 2 quarters · filed 2026-05-07 | 260.67M shares derived: average of 3 quarters · filed 2026-05-07 | 263.28M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 240.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 257.48M shares derived: average of 2 quarters · filed 2026-02-26 | 262.02M shares derived: average of 3 quarters · filed 2026-08-05 | 257.16M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 274.37M shares 10-Q · filed 2025-11-10 | 272.74M shares derived: average of 2 quarters · filed 2026-08-05 | 262.68M shares 10-Q · filed 2025-11-10 | 251.46M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 271.10M shares 10-Q · filed 2026-08-05 | 256.54M shares 10-Q · filed 2026-08-05 | 243.82M shares derived: average of 3 quarters · filed 2026-08-05 | 235.45M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 241.60M shares 10-Q · filed 2026-05-07 | 230.18M shares derived: average of 2 quarters · filed 2026-05-07 | 223.57M shares derived: average of 3 quarters · filed 2026-05-07 | 220.10M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 218.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 214.55M shares derived: average of 2 quarters · filed 2026-02-26 | 212.94M shares derived: average of 3 quarters · filed 2026-02-26 | 210.95M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 210.35M shares 10-Q · filed 2025-11-10 | 210.03M shares derived: average of 2 quarters · filed 2025-11-10 | 208.34M shares 10-Q · filed 2025-11-10 | 203.73M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 209.71M shares 10-Q · filed 2025-08-07 | 207.33M shares 10-Q · filed 2025-08-07 | 201.53M shares derived: average of 3 quarters · filed 2026-02-26 | 198.22M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 204.96M shares 10-Q · filed 2025-05-08 | 197.44M shares derived: average of 2 quarters · filed 2026-02-26 | 194.40M shares derived: average of 3 quarters · filed 2026-02-26 | 192.50M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 189.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 189.12M shares derived: average of 2 quarters · filed 2026-02-26 | 188.35M shares derived: average of 3 quarters · filed 2026-02-26 | 187.47M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 188.31M shares 10-Q · filed 2024-11-07 | 187.56M shares derived: average of 2 quarters · filed 2024-11-07 | 186.64M shares 10-Q · filed 2024-11-07 | 185.97M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 186.82M shares 10-Q · filed 2024-08-08 | 185.80M shares 10-Q · filed 2024-08-08 | 185.20M shares derived: average of 3 quarters · filed 2024-08-08 | 184.87M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 184.77M shares 10-Q · filed 2024-05-09 | 184.39M shares derived: average of 2 quarters · filed 2024-05-09 | 184.22M shares derived: average of 3 quarters · filed 2024-05-09 | 185.76M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 184.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 183.94M shares derived: average of 2 quarters · filed 2024-03-14 | 186.09M shares derived: average of 3 quarters · filed 2024-03-14 | 182.78M shares 10-K · filed 2024-03-14 |
| 2022-09-30 | 183.88M shares 10-Q · filed 2023-11-08 | 187.13M shares derived: average of 2 quarters · filed 2023-11-08 | 182.38M shares 10-Q · filed 2023-11-08 | 182.13M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 190.38M shares 10-Q · filed 2023-08-28 | 181.61M shares 10-Q · filed 2023-08-28 | 181.54M shares derived: average of 3 quarters · filed 2023-08-28 | 179.60M shares derived: average of 4 quarters · filed 2023-08-28 |
| 2022-03-31 | 179.60M shares 10-Q · filed 2023-05-08 | 177.12M shares derived: average of 2 quarters · filed 2023-08-28 | 176.01M shares derived: average of 3 quarters · filed 2023-08-28 | 172.34M shares derived: average of 4 quarters · filed 2023-08-28 |
| 2021-12-31 | 174.65M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | 174.21M shares derived: average of 2 quarters · filed 2023-08-28 | 169.92M shares derived: average of 3 quarters · filed 2023-08-28 | 165.95M shares 10-K/A · filed 2023-08-28 |
| 2021-09-30 | 173.78M shares 10-Q · filed 2022-11-03 | 167.56M shares derived: average of 2 quarters · filed 2022-11-03 | 163.05M shares 10-Q · filed 2022-11-03 | 158.52M shares derived: average of 4 quarters · filed 2023-08-28 |
| 2021-06-30 | 161.33M shares 10-Q · filed 2022-08-04 | 157.60M shares 10-Q · filed 2022-08-04 | 153.44M shares derived: average of 3 quarters · filed 2023-08-28 | 150.91M shares derived: average of 4 quarters · filed 2023-08-28 |
| 2021-03-31 | 153.82M shares 10-Q · filed 2022-05-09 | 149.49M shares derived: average of 2 quarters · filed 2023-08-28 | 147.43M shares derived: average of 3 quarters · filed 2023-08-28 | |
| 2020-12-31 | 145.16M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | 144.24M shares derived: average of 2 quarters · filed 2023-08-28 | 138.46M shares 10-K/A · filed 2023-08-28 | |
| 2020-09-30 | 143.31M shares 10-Q · filed 2021-11-04 | 136.23M shares 10-Q · filed 2021-11-04 | ||
| 2019-12-31 | 118.40M shares 10-K · filed 2022-03-01 | |||
| 2017-12-31 | 49.72M shares 10-K · filed 2019-03-26 | 48.33M shares derived: average of 2 quarters · filed 2019-03-26 | 45.83M shares derived: average of 3 quarters · filed 2019-03-26 | 44.06M shares derived: average of 4 quarters · filed 2019-03-26 |
| 2017-09-30 | 46.94M shares 10-K · filed 2019-03-26 | 43.88M shares derived: average of 2 quarters · filed 2019-03-26 | 42.17M shares derived: average of 3 quarters · filed 2019-03-26 | |
| 2017-06-30 | 40.82M shares 10-K · filed 2019-03-26 | 39.79M shares derived: average of 2 quarters · filed 2019-03-26 | ||
| 2017-03-31 | 38.76M shares 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |